-+ 0.00%
-+ 0.00%
-+ 0.00%

Bora Pharmaceuticals buys MacroGenics Maryland CDMO assets for USD 122.5 million

PUBT·05/11/2026 23:00:28
Listen to the news
Bora Pharmaceuticals buys MacroGenics Maryland CDMO assets for USD 122.5 million
  • Bora Pharmaceuticals to buy CDMO operating assets in Maryland from MacroGenics for USD 122.5 million in cash through newly formed Bora Biologics USA.
  • Deal covers operating equipment, employees, existing leased facility totaling 139,600 square feet.
  • Transaction aims to expand Bora’s US CDMO commercialization footprint.
  • BDO Taiwan appraisal valued assets at USD 119.88 million to USD 135.63 million.
  • Board and audit committee signed off on May 11, 2026; closing timing tied to local regulatory process.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bora Pharmaceuticals Co. Ltd. published the original content used to generate this news brief on May 11, 2026, and is solely responsible for the information contained therein.